{"disease":{"id":"hypertrophic-cardiomyopathy-hcm","name":"hypertrophic cardiomyopathy hcm"},"drugs":{"marketed":[{"drug_id":"mavacamten","indication_name":"Obstructive hypertrophic cardiomyopathy (HCM)","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Camzyos","generic_name":"MAVACAMTEN","company_name":"Bristol-Myers Squibb","drug_phase":"marketed","molecular_target":"cardiac myosin","drug_class":"Cardiac Myosin Inhibitor [EPC]","quality_score":65,"revenue":"600","mechanism":"Mavacamten selectively inhibits cardiac myosin, reducing force-producing cross-bridge formation and improving cardiac function in HCM."},{"drug_id":"myk-461","indication_name":"Obstructive hypertrophic cardiomyopathy (HCM)","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Camzyos","generic_name":"MYK-461","company_name":"Myokardia Inc","drug_phase":"marketed","molecular_target":"Myosin-7","drug_class":"Cardiac Myosin Inhibitor [EPC]","quality_score":51,"revenue":null,"mechanism":"Camzyos works by inhibiting the Myosin-7 protein, which is involved in the thickening of heart muscle cells."}],"pipeline":[],"offLabel":[],"totalMarketed":2,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06607471","title":"Multimodal and Multidisciplinary Approach to Optimize Diagnostic, Prognostic, and Therapeutic Management of Patients with Non-ischemic Cardiomyopathies and Arrhythmogenic-inflammatory Phenotypes: a Multicenter, Observational, Retrospective and Prospective Registry Study.","phase":"","overall_status":"RECRUITING","enrollment_count":15000,"lead_sponsor_name":"Scientific Institute San Raffaele","has_results":false},{"nct_id":"NCT07263204","title":"AI-Enabled Diagnosis and Prognosis of Hypertrophic Cardiomyopathy","phase":"","overall_status":"RECRUITING","enrollment_count":15000,"lead_sponsor_name":"Second Affiliated Hospital, School of Medicine, Zhejiang University","has_results":false},{"nct_id":"NCT04189822","title":"Hearts in Rhythm Organization (HiRO)National Registry and Bio Bank","phase":"","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":10000,"lead_sponsor_name":"University of British Columbia","has_results":false},{"nct_id":"NCT07336290","title":"One-stop Evaluation of Hypertrophic Cardiomyopathy in Cardiac Magnetic Resonance","phase":"","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":10000,"lead_sponsor_name":"Minjie Lu","has_results":false},{"nct_id":"NCT06748261","title":"AI-enabled Screening and Diagnosis of Cardiomyopathies Using Coronary CTA","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":5000,"lead_sponsor_name":"Shanghai Zhongshan Hospital","has_results":false},{"nct_id":"NCT06775665","title":"A Real-World Study on Hypertrophic Cardiomyopathy in Chinese Population","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":3000,"lead_sponsor_name":"Second Affiliated Hospital, School of Medicine, Zhejiang University","has_results":false},{"nct_id":"NCT07381894","title":"Multicentre Hypertrophic Cardiomyopathy Registry","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":2500,"lead_sponsor_name":"University of Manchester","has_results":false},{"nct_id":"NCT07354646","title":"The Application of T1 Mapping in Real-World","phase":"","overall_status":"RECRUITING","enrollment_count":2000,"lead_sponsor_name":"Chinese Academy of Medical Sciences, Fuwai Hospital","has_results":false},{"nct_id":"NCT07295613","title":"ReGistry of hypeRtrophic cArDIomyopathy: Regional fEatures, geNeTics and Course","phase":"","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":1400,"lead_sponsor_name":"Central State Medical Academy","has_results":false},{"nct_id":"NCT06813443","title":"Characterization of Patients With Cardiomyopathy to Identify Critical Patients Candidates for Cardiac Transplantation","phase":"","overall_status":"RECRUITING","enrollment_count":700,"lead_sponsor_name":"IRCCS Azienda Ospedaliero-Universitaria di Bologna","has_results":false},{"nct_id":"NCT07202897","title":"LA-HCM Study : Rivaroxaban for Antithrombotic Prevention in Hypertrophic Cardiomyopathy Patients With Abnormal Left Atrial Strain.","phase":"PHASE3","overall_status":"NOT_YET_RECRUITING","enrollment_count":532,"lead_sponsor_name":"Rennes University Hospital","has_results":false},{"nct_id":"NCT06372457","title":"COLLIGO-HCM: A Multinational Observational Study of the Real-World Effectiveness of Mavacamten Among Patients With Symptomatic Obstructive Hypertrophic Cardiomyopathy (oHCM)","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":500,"lead_sponsor_name":"Bristol-Myers Squibb","has_results":false},{"nct_id":"NCT06609382","title":"Left Ventricular Mass Index Predicts Clinical Outcomes in Patients with Obstructive Hypertrophic Cardiomyopathy Undergoing Septal Myectomy","phase":"","overall_status":"COMPLETED","enrollment_count":490,"lead_sponsor_name":"Changrong Nie","has_results":false},{"nct_id":"NCT06794710","title":"Early Identification and Treatment of Rare Cardiomyopathy Cohorts","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":300,"lead_sponsor_name":"RenJi Hospital","has_results":false},{"nct_id":"NCT05186818","title":"Phase 3 Trial to Evaluate the Efficacy and Safety of Aficamten Compared to Placebo in Adults With Symptomatic oHCM","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":282,"lead_sponsor_name":"Cytokinetics","has_results":true},{"nct_id":"NCT07529938","title":"Mavacamten in Adult Patients With Obstructive Hypertrophic Cardiomyopathy","phase":"","overall_status":"COMPLETED","enrollment_count":222,"lead_sponsor_name":"Chinese Academy of Medical Sciences, Fuwai Hospital","has_results":false},{"nct_id":"NCT07359690","title":"Multimodal Analysis of Endomyocardial Biopsies","phase":"","overall_status":"RECRUITING","enrollment_count":216,"lead_sponsor_name":"University Hospital, Essen","has_results":false},{"nct_id":"NCT07383025","title":"Mavacamten Post-marketing Surveillance in Patients With Obstructive Hypertrophic Cardiomyopathy in Japan","phase":"","overall_status":"RECRUITING","enrollment_count":200,"lead_sponsor_name":"Bristol-Myers Squibb","has_results":false},{"nct_id":"NCT06683872","title":"Evaluation of Clinical Efficacy and Prognosis in Patients With Hypertrophic Obstructive Cardiomyopathy Through Hemodynamic Modeling Reconstructed by CT","phase":"","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":200,"lead_sponsor_name":"Zhejiang Provincial People's Hospital","has_results":false},{"nct_id":"NCT05767346","title":"Phase 3 Trial to Evaluate the Efficacy and Safety of Aficamten Compared to Metoprolol Succinate in Adults With Symptomatic oHCM","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":175,"lead_sponsor_name":"Cytokinetics","has_results":false},{"nct_id":"NCT07168655","title":"Mavacamten in Obstructive Hypertrophic Cardiomyopathy","phase":"","overall_status":"COMPLETED","enrollment_count":163,"lead_sponsor_name":"Bristol-Myers Squibb","has_results":false},{"nct_id":"NCT07107373","title":"A Study to Assess the Treatment of Obstructive Hypertrophic Cardiomyopathy (oHCM) With Mavacamten in the US","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":150,"lead_sponsor_name":"Bristol-Myers Squibb","has_results":false},{"nct_id":"NCT00753233","title":"Identification of Risk Factors for Arrhythmia in Children and Adolescents With Hypertrophic Cardiomyopathy","phase":"","overall_status":"COMPLETED","enrollment_count":145,"lead_sponsor_name":"National Heart, Lung, and Blood Institute (NHLBI)","has_results":false},{"nct_id":"NCT07103655","title":"The Therapeutic Value of Mavacamten in Hypertrophic Cardiomyopathy With Mid-to-Apical Left Ventricular Obstruction","phase":"PHASE4","overall_status":"NOT_YET_RECRUITING","enrollment_count":132,"lead_sponsor_name":"Second Affiliated Hospital, School of Medicine, Zhejiang University","has_results":false},{"nct_id":"NCT06338202","title":"Real-World Effectiveness of Mavacamten in Canada","phase":"","overall_status":"COMPLETED","enrollment_count":115,"lead_sponsor_name":"Bristol-Myers Squibb","has_results":false},{"nct_id":"NCT07344480","title":"Retrospective Natural History Study of RASopathy-associated Cardiomyopathy (RAS-CM)","phase":"","overall_status":"RECRUITING","enrollment_count":100,"lead_sponsor_name":"Deutsches Herzzentrum Muenchen","has_results":false},{"nct_id":"NCT04219826","title":"Dose-finding Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of CK-3773274 in Adults With Hypertrophic Cardiomyopathy","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":96,"lead_sponsor_name":"Cytokinetics","has_results":true},{"nct_id":"NCT06882668","title":"Role of Cardiovascular Imaging in the Early Diagnosis of Hypertrophic Cardiomyopathy in Women","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":80,"lead_sponsor_name":"IRCCS San Raffaele","has_results":false},{"nct_id":"NCT07367724","title":"Ademetionine in Obstructive Hypertrophic Cardiomyopathy","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":44,"lead_sponsor_name":"China National Center for Cardiovascular Diseases","has_results":false},{"nct_id":"NCT07454135","title":"Mechanisms of Atrial Pathoelectrophysiology in HCM","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":40,"lead_sponsor_name":"Guy's and St Thomas' NHS Foundation Trust","has_results":false},{"nct_id":"NCT07155434","title":"ENABLE-HCM - AI-ENabled Echocardiography With Ultrasound Beyond the Echo Lab for Better HCM Imaging and Expanded Access","phase":"","overall_status":"TERMINATED","enrollment_count":36,"lead_sponsor_name":"UltraSight","has_results":false},{"nct_id":"NCT07464132","title":"Application of [68Ga]Ga-NI-FAPI-04 PET/CT Imaging in Fibroblast Activation Protein Related Diseases","phase":"PHASE1, PHASE2","overall_status":"RECRUITING","enrollment_count":30,"lead_sponsor_name":"Peking Union Medical College Hospital","has_results":false},{"nct_id":"NCT06599229","title":"Perfusion Abnormalities in Hypertrophic Cardiomyopathy","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":30,"lead_sponsor_name":"University of Virginia","has_results":false}],"total":33},"guidelines":[],"source":"Drug Landscape verified database"}